What does Soleus Capital Management, L.P. hold? Q1 2026 13F Holdings & Portfolio

AI Analysis · Q1 2026 · Q1 2026

Soleus Capital Management, L.P. filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight

KRYSTAL BIOTECH INC

$298M1.2M12.1%

CELCUITY INC

$147M1.3M5.9%

TG THERAPEUTICS INC

$134M4.0M5.4%

INSULET CORP

$118M563K4.8%

NOVOCURE LTD

$114M10.5M4.6%

UNITED THERAPEUTICS CORP DEL

$111M187K4.5%

PRAXIS PRECISION MEDICINES I

$106M331K4.3%

VERICEL CORP

$82M2.5M3.3%

ALKERMES PLC

$70M2.0M2.8%

ANI PHARMACEUTICALS INC

$63M820K2.6%

Filing history loading…